EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cleopatra Hospital Co's enterprise value is E£10,634 Mil.
Cleopatra Hospital Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was E£858 Mil. Therefore, Cleopatra Hospital Co's EV-to-EBITDA for today is 12.39.
The historical rank and industry rank for Cleopatra Hospital Co's EV-to-EBITDA or its related term are showing as below:
CAI:CLHO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.89 Med: 13.43 Max: 29.69
Current: 12.39
During the past 9 years, the highest EV-to-EBITDA of Cleopatra Hospital Co was 29.69. The lowest was 2.89. And the median was 13.43.
CAI:CLHO's EV-to-EBITDA is ranked worse than 50.22% of 464
companies
in the Healthcare Providers & Services industry
Industry Median: 12.735
vs CAI:CLHO: 12.39
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Cleopatra Hospital Co EV-to-EBITDA Historical Data
The historical data trend for Cleopatra Hospital Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cleopatra Hospital Co's EV-to-EBITDA
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's EV-to-EBITDA falls into.
Cleopatra Hospital Co's current Enterprise Value is E£10,634 Mil.
Cleopatra Hospital Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£858 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cleopatra Hospital Co (CAI:CLHO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Cleopatra Hospital Co's PE Ratio for today is calculated as:
Cleopatra Hospital Co's share price for today is E£7.00.
Cleopatra Hospital Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Cleopatra Hospital Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Cleopatra Hospital Co (CAI:CLHO) Business Description
Cleopatra Hospital Co is a private hospital in Egypt. The company provides health and medical services, as well as the medical care of inpatients. Its operating segment based on hospitals includes Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawi Hospital, Al Shorouk Hospital, CHG for Medical Services, CHG Pharma for pharmacies management, CHG for Hospitals, Queens Hospitals and Al Kateb Hospitals. It generates maximum revenue from the Cleopatra Hospital Company segment. The company derives revenue from Accommodation and medical supervision, Surgeries, Outpatient clinics, Laboratories, Cardiac catheterization, Service charge, Radiology, Emergency, Oncology center, Pharmacy, Dentistry, Physiotherapy, Endoscopy, Cardiac tests, and Other services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CAI:CLHO has been successfully added to your 